Among non-hematological toxicities, fatigue (55%), alopecia (42.5%), increased alanine aminotransferase (ALT) (37.5%), and diarrhea (35%) were the most frequent treatment emergent adverse effects. The gene discussed is GPT; the disease is alopecia.